ask="0.4550"
ask_size="400"
average_daily_volume="1692410"
bid="0.3000"
bid_size="5000"
book_value="0.1680"
change="-0.0075"
change_from_200_day_moving_average="-0.0561"
change_from_50_day_moving_average="-0.0178"
change_from_52_week_high="-0.8251"
change_From_52_week_low="0.0129"
change_in_percent="-2.4802%"
close="0.2949"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2040"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.1100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.3099"
high_52_weeks="1.1200"
last_trade_date="1/27/2017"
last_trade_price="0.2949"
last_trade_size="1215"
last_trade_time="4:00pm"
low="0.2940"
low_52_weeks="0.2820"
market_capitalization="75.83M"
moving_average_200_day="0.3510"
moving_average_50_day="0.3127"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.2500"
open="0.3000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-15.9865%"
percent_change_from_50_day_moving_average="-5.7005%"
percent_change_from_52_week_high="-73.6696%"
percent_change_from_52_week_low="+4.5745%"
previous_close="0.3024"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.8000"
price_per_sales="1.4275"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.2600"
stock_exchange="NCM"
symbol="PPHM"
volume="1116861"
weeks_range_52="0.2820 - 1.1200"
